Genetic intestinal disease

Genetic intestinal disease (Orphanet code 165655) is a broad classification category within Orphanet that encompasses a heterogeneous group of rare inherited disorders primarily affecting the gastrointestinal tract. This grouping includes a wide range of conditions in which genetic mutations lead to structural, functional, or inflammatory abnormalities of the intestines. These disorders can affect nutrient absorption, intestinal motility, epithelial barrier integrity, and immune regulation within the gut. Conditions falling under this umbrella may include congenital enteropathies, familial forms of inflammatory bowel disease, intestinal polyposis syndromes, congenital diarrheal disorders, and other monogenic intestinal conditions. Because this is a classification category rather than a single discrete disease entity, the clinical presentation varies enormously depending on the specific underlying condition. Symptoms may include chronic diarrhea, malabsorption, failure to thrive, intestinal obstruction, rectal bleeding, abdominal pain, and nutritional deficiencies. Age of onset ranges from the neonatal period to adulthood. Treatment approaches are highly variable and depend on the specific diagnosis, ranging from dietary modifications and nutritional support to immunosuppressive therapies, enzyme replacement, and surgical interventions. Genetic testing and next-generation sequencing panels have become increasingly important in establishing precise diagnoses within this broad category, enabling more targeted management strategies.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Genetic intestinal disease